Boehringer Ingelheim

Pharma

Licensing deals, AI pact and Novo vs. KBP—Fierce Pharma Asia

Dianthus and Boehringer headlined the latest round of licensing deals featuring China biotechs. Takeda inked its second pact with Nabla Bio. And more.

Eric Sagonowsky Oct 17, 2025 9:40am

Stylized 3D rendering of a DNA double helix structure set against a purple and pink background with molecular particles floa

How Boehringer Ingelheim is buttressing its US business

Oct 10, 2025 9:00am

Boehringer breaks IPF treatment drought with new FDA approval

Oct 8, 2025 8:56am

drug medicine shopping cart consumer health dtc

Novartis, Boehringer debut DTC programs with reduced drug prices

Sep 29, 2025 12:06pm

A photo finish at a horse race with both horses crossing the finish line

Sobi tops Roche in rare disease patients' reputation rankings

Sep 23, 2025 12:33pm

Boehringer's lung cancer med passes muster with the FDA

Aug 8, 2025 3:52pm